Nevoid basal cell carcinoma syndrome

Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant tumor-predisposition disorder with high penetrance and strikingly variable expressivity, defined by the combination of multiple odontogenic keratocysts (OKCs) of the jaws, early-onset basal cell carcinomas (BCCs), palmoplantar pits, and lamellar falx cerebri calcification.[1][2][3] Most cases arise from germline loss-of-function variants in PTCH1, a tumor suppressor that restrains Sonic hedgehog (SHH) signaling; haploinsufficiency with a somatic second hit drives constitutive pathway activation and tumorigenesis.[1][3][4] A minority result from SUFU variants, and PTCH2 is no longer considered an established cause.[5]

For the oral and maxillofacial radiologist, the signature finding is multiple jaw keratocysts, which are frequently the earliest and most consistent manifestation and are often what first brings the patient to attention.[1][6] The jaw cysts behave locally aggressively and recur, management is surgical with lifelong multidisciplinary surveillance, and ionizing radiation should be minimized because affected tissue is radiosensitive for BCC induction.[7]

The condition is reported under several interchangeable names: NBCCS, Gorlin syndrome, Gorlin–Goltz syndrome, basal cell nevus syndrome (BCNS), and basal cell carcinoma nevus syndrome (OMIM #109400).[8][9] The jaw lesion itself has an unstable nomenclature worth clarifying to avoid confusion: the WHO termed it odontogenic keratocyst historically, reclassified it as keratocystic odontogenic tumor (KCOT) in 2005 on the basis of aggressive behavior and PTCH1 mutations, then reverted to odontogenic keratocyst in the 2017 classification, a designation retained in the 2022 (fifth edition) classification.[10][11][18] Only the parakeratinized variant was ever designated KCOT; the orthokeratinized odontogenic cyst is a separate, less aggressive entity.[13][18]

Reported prevalence ranges widely, from roughly 1 in 31,000 to 1 in 256,000, with birth incidence estimated as high as 1 in 19,000; underdiagnosis and incomplete mutation detection make true figures uncertain.[3][8] There is no sex predilection (male-to-female ratio approximately 1:1) and no clear ethnic restriction, although phenotype frequencies differ by population.[3][14] Northern European cohorts show higher rates of BCC, falx calcification, and palmoplantar pits, whereas East Asian cohorts show higher rates of keratocysts, cleft lip/palate, and hypertelorism.[1]

Jaw keratocysts are among the most penetrant features, affecting roughly 65–100% of patients, and typically appear earlier than BCCs—commonly in the first and second decades, often by age 10.[1][8][15] BCCs cluster in the late teens to early adulthood, reaching 90% or more by age 40 in high-UV European populations but occurring far less frequently in more pigmented populations.[16] In unselected OKC specimen archives, roughly 5–17% of patients prove to have NBCCS.[17][18]

Diagnosis rests on established clinical criteria, generally requiring two major, or one major plus two minor, criteria (with molecular confirmation substituting for a major criterion in some schemes).[2][14] Major criteria include multiple BCCs or a BCC before age 20, histologically proven jaw OKC, three or more palmar/plantar pits, lamellar falx cerebri calcification, bifid/fused/splayed ribs, and a first-degree relative with NBCCS.[14][18] Minor criteria include macrocephaly, frontal bossing, hypertelorism, cleft lip/palate, other skeletal and radiologic anomalies, ovarian or cardiac fibroma, and medulloblastoma.[18][19]

Key clinical points:

• Jaw cysts are frequently asymptomatic and found incidentally, but larger lesions cause painless swelling, intraoral or facial expansion, tooth displacement, malocclusion, and occasionally pain, drainage, or pathologic fracture.[10][20]
• Cutaneous findings: multiple BCCs ranging from skin-colored papules to ulcerated plaques, palmoplantar pits accentuated by soaking, and facial milia.[3][16]
• Craniofacial dysmorphism: macrocephaly, frontal/parietal bossing, hypertelorism, and occasional mandibular prognathism.[21][22]
• Red flags / complications: medulloblastoma (desmoplastic/SHH-activated subtype, typically in the first three years of life), cardiac fibroma (risk of arrhythmia), and ovarian fibroma. Medulloblastoma can be the presenting malignancy, and radiotherapy for it induces numerous BCCs within the field.[5][23][24]

Tempo is lifelong and cumulative: new keratocysts and new BCCs continue to develop over decades, demanding ongoing rather than one-time evaluation.[3]

The jaw keratocyst is the dominant radiographic feature and is the lesion the maxillofacial radiologist is most likely to detect first. In NBCCS the cysts are characteristically multiple and often bilateral, a pattern that itself should prompt consideration of the syndrome.[25][26][27]

Location and distribution

Lesions favor the posterior mandible—angle, ramus, and molar region—followed by the mandibular body and the posterior maxilla, mirroring sporadic OKC but in multiplicity and at younger ages.[26][28][29] The mandible-to-maxilla ratio is roughly 2:1.[29] Syndromic cysts tend to involve all four quadrants over time and more often occupy sites unusual for sporadic disease.[30][31] In the maxilla, lesions commonly invaginate and nearly fill the antrum and may approach the nasal floor.[32]

Periphery and shape

Cysts are well-defined with a thin corticated (sclerotic) margin. The outline is frequently smooth and rounded, but a substantial proportion show a scalloped or lobulated periphery reflecting the lesion's irregular growth.[18][33]

Internal architecture

Most are unilocular radiolucencies, particularly when small; larger lesions may become multilocular/pseudomultilocular, and apparent loculation often represents folding of the lining rather than true septation.[18][34] Internal content is uniformly radiolucent without mineralization.

Effects on teeth and the alveolar process

A keratocyst commonly encloses or abuts an unerupted tooth in a dentigerous-like relationship (approximately 30–47% of cases), most often an impacted third molar, and may displace teeth.[18] Distinguishing features that favor keratocyst over more aggressive mimics are relative sparing of tooth position and roots: tooth displacement is less frequent (about 29%) and root resorption is uncommon (roughly 6%) compared with ameloblastoma.[18]

Growth pattern, cortical involvement, and extent

The hallmark is growth along the medullary cavity with marked mesiodistal (anteroposterior) extension and disproportionately little buccolingual expansion—a fusiform pattern described as nearly pathognomonic and contrasting sharply with the "ballooning" expansion of ameloblastoma.[18] Expansion and buccolingual widening become evident only in larger lesions; cross-sectional assessment better demonstrates true buccolingual dimension, cortical thinning, and perforation that plain images underestimate.[18] Keratocysts generally show less cortical destruction and smaller volumes than ameloblastomas of comparable location; when an OKC does breach cortex it tends to be large.[35] Extension into adjacent soft tissue occurs but is uncommon.

Variants

Recognized presentations include small incidental unilocular lucencies, large multilocular expansile lesions, a dentigerous (pericoronal) pattern, and—rarely—peripheral (soft-tissue) and solid variants.[36] In the syndrome, serial imaging characteristically reveals metachronous new cysts distinct from recurrence at prior sites.[37][38]

Extragnathic imaging findings are diagnostically decisive because several are major or minor criteria and because they direct syndrome-specific surveillance.

Intracranial calcification

Lamellar (bilamellar) calcification of the falx cerebri is the most frequent radiologic feature, approaching near-universal frequency in adults and present in a substantial minority of children; it appears as dense midline sheet-like calcification.[39][40] Tentorium cerebelli calcification (about 20%) and sella bridging (about 68%) also occur.[39] Lamellar falx calcification before age 20 is strongly suggestive of the syndrome.[41]

Rib and skeletal anomalies

Bifid, fused, splayed, or otherwise misshapen ribs (most often third to fifth) are seen in roughly a quarter of patients, with additional splayed/fused ribs in others.[39][42] Vertebral anomalies (hemivertebrae, fusion), nuchal ligament calcification, flame-shaped lucencies of the metacarpals and phalanges, and short fourth metacarpals are reported.[39]

Visceral tumors

Ovarian fibromas (frequently calcified, bilateral) and cardiac fibromas are detectable on ultrasound/cross-sectional imaging and warrant targeted screening.[24] Medulloblastoma on brain imaging, particularly in infancy, is a sentinel malignancy.[5][23]

Because the index radiographic abnormality is one or more corticated jaw radiolucencies, the differential centers on other odontogenic and intraosseous lesions; multiplicity and bilaterality raise suspicion for the syndrome itself. Biopsy is required for definitive diagnosis in essentially all cases.

The highest-risk pitfall is dismissing multiple or recurrent jaw radiolucencies—or a single keratocyst in a young patient—as isolated odontogenic cysts and missing NBCCS. Any histologically confirmed OKC, particularly when multiple, bilateral, or in a patient under 20, should trigger evaluation for the syndrome, including skull/skeletal imaging for falx and rib changes and referral for genetic assessment.[25][30][44] Aspiration yielding thick, cheesy keratinaceous material and low protein supports keratocyst preoperatively, but histopathology is confirmatory.[10]

The OKC has a diagnostic microscopic appearance:[18][45]

• A thin, uniform parakeratinized stratified squamous epithelium, typically 5–10 cell layers thick, with a corrugated (wavy) luminal surface.[18][34]
• A well-defined, palisaded basal layer of cuboidal-to-columnar cells with hyperchromatic nuclei showing reversal of polarity.[18][28]
• A flat epithelial–connective tissue interface lacking rete ridges, with frequent artifactual separation of the epithelium from a thin, uninflamed fibrous wall.[18][29]
• Suprabasal and basal mitotic figures are characteristic and more prominent than in other odontogenic cysts.[18]

Inflammation alters this picture, inducing loss of keratinization and a non-specific squamous lining that can mimic a dentigerous or radicular cyst.[45][46] Keratin 10 and keratin 17/19 profiles support the diagnosis and distinguish OKC from the orthokeratinized odontogenic cyst.[13][45]

Radiologic-pathologic correlation: the scalloped radiographic margin corresponds to the irregular, budding growth of the lining into adjacent marrow, and the mesiodistal/intramedullary growth reflects active epithelial proliferation rather than hydrostatic expansion.[18][47]

Syndromic features and molecular findings: NBCCS-associated cysts more often show epithelial budding, daughter (satellite) cysts, and solid odontogenic rests in the wall, features linked to recurrence, though none is individually diagnostic of syndromic status.[29][30] Both syndromic and sporadic OKCs demonstrate PTCH1 inactivation and constitutive SHH signaling (upregulated GLI).[11][15]

Workup and referral. Confirm the jaw lesion histologically, then evaluate for the full syndrome with skin examination, skull and skeletal imaging for falx and rib criteria, and referral for genetic counseling and PTCH1/SUFU testing; care is best coordinated by a multidisciplinary team including oral/maxillofacial surgery, dermatology, genetics, and (in children) neurology.[7][9][48] First-degree relatives should be offered testing because surveillance and radiation-avoidance hinge on genetic status.[7]

Definitive treatment of jaw keratocysts. Options range from conservative to aggressive: marsupialization/decompression, enucleation and curettage, enucleation with adjuncts (Carnoy's solution, peripheral ostectomy, cryotherapy), and resection for extensive, recurrent, or cortically perforating lesions.[33][49] Enucleation with Carnoy's solution is a common, effective first-line approach.[50] Selection balances lesion size, cortical integrity, access, and especially patient age—conservative, dentition- and growth-sparing approaches are favored in children, reserving aggressive surgery for recurrent or extensive disease.[25] Hedgehog pathway inhibition (vismodegib) can shrink keratocysts and is a non-surgical option in patients facing repeated disfiguring surgery, though durability after discontinuation and tolerability are limiting.[15]

Recurrence and surveillance. Syndromic keratocysts recur and develop as new lesions far more often than sporadic OKCs—reported recurrence/new-lesion rates reach 60% and higher, up to ~83% in some cohorts—so prolonged follow-up (at least 7 years, generally longer) is mandatory.[50][51] Guideline-based surveillance includes orthopantomography every 12–18 months from about age 8 for keratocysts, at least annual dermatologic skin examination, head-circumference monitoring and developmental assessment in young children, ophthalmologic evaluation, and ovarian ultrasound in women at age 18.[7] Ionizing radiation should be minimized—diagnostic radiographs used sparingly and radiotherapy avoided where alternatives exist, since both induce BCCs and, after craniospinal irradiation, meningiomas.[7][9]

Prognosis. Life expectancy is generally near-normal, but morbidity from recurrent keratocysts, cumulative BCCs, and surgical disfigurement is substantial; malignant transformation of keratocysts is rare.[3] Early diagnosis improves outcomes by enabling radiation-sparing, timely surveillance for medulloblastoma and other tumors, and sun protection.[3][8]

Genotype-driven surveillance

Genotype meaningfully changes management. PTCH1-related NBCCS carries the characteristic jaw keratocysts and a low absolute medulloblastoma risk (~0.4–1.1%), so routine brain MRI is generally not warranted. SUFU-related NBCCS carries a substantially higher medulloblastoma risk (estimates range from about 7% to 33%) and increased meningioma risk, warranting intensive brain MRI surveillance in early childhood, whereas jaw keratocysts are rare in SUFU carriers.[5][7] This divergence makes molecular classification clinically actionable rather than merely confirmatory.

Pediatric and radiation considerations

Because keratocysts and medulloblastoma present in childhood, and because PTCH1-mutant tissue is hypersensitive to ionizing and UV radiation, pediatric management emphasizes radiation avoidance (orthopantomography every 12–18 months from about age 8, with MRI as a radiation-sparing alternative where available), strict sun protection, and growth-preserving cyst surgery.[5][7][52]